Evidence map›Paper›PMID 40724001›Full record

ArticleAntibiotics (Basel, Switzerland)2025

Antimicrobial Peptides SET-M33L and SET-M33L-PEG Are Promising Agents Against Strong Biofilm-Forming

Alessio Fontanot, Peter D Croughs, Clelia Cortese, Adrianus C J M de Bruijn, Chiara Falciani, Alessandro Pini, Isabella Ellinger, Wendy W J Unger, John P Hays

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessio FontanotLaboratory of Pediatrics, Department of Pediatrics, Sophia Children's Hospital, Erasmus University Medical Center (Erasmus MC), 3015 GD Rotterdam, The Netherlands.ORCID 0009-0000-1022-9720
Peter D CroughsDepartment of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center (Erasmus MC), 3015 GD Rotterdam, The Netherlands.
Clelia CorteseDepartment of Medical Biotechnology, University of Siena, via A. Moro 2, 53100 Siena, Italy.ORCID 0009-0007-0778-4855
Adrianus C J M de BruijnLaboratory of Pediatrics, Department of Pediatrics, Sophia Children's Hospital, Erasmus University Medical Center (Erasmus MC), 3015 GD Rotterdam, The Netherlands.
Chiara FalcianiDepartment of Medical Biotechnology, University of Siena, via A. Moro 2, 53100 Siena, Italy.ORCID 0000-0002-1027-8482
Alessandro PiniDepartment of Medical Biotechnology, University of Siena, via A. Moro 2, 53100 Siena, Italy.ORCID 0000-0002-3832-8349
Isabella EllingerInstitute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-6335-076X
Wendy W J UngerLaboratory of Pediatrics, Department of Pediatrics, Sophia Children's Hospital, Erasmus University Medical Center (Erasmus MC), 3015 GD Rotterdam, The Netherlands.ORCID 0000-0001-9484-261X
John P HaysDepartment of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center (Erasmus MC), 3015 GD Rotterdam, The Netherlands.ORCID 0000-0001-9183-4497

Funding

Horizon Europe MSCA 101073263
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial peptidesbiofilmmultidrug resistancePseudomonas aeruginosaSET-M33LSET-M33L-PEG

Identifiers

PMID40724001
PMCPMC12291782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.